![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
The Cell Signalling Laboratory, Leicester School of Pharmacy, De Montfort University, Leicester, United Kingdom
Hepatocyte function is regulated by several P2Y receptor subtypes. Here we report that 2-methylthioadenosine 5'-diphosphate (2-MeSADP), an agonist at P2Y1, P2Y12, and P2Y13 receptors, potently (threshold 30 nM) stimulates glycogen phosphorylase in freshly isolated rat hepatocytes. Antagonism by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate (MRS 2179) confirms that this response is mediated by P2Y1 receptors. In addition, in these cells, both 2-MeSADP and UTP inhibited glucagon-stimulated cyclic AMP accumulation. This inhibitory effect of 2-MeSADP was not reversed by the P2Y1 antagonists, adenosine-3'-phosphate-5'-phosphate (A3P5P) or MRS 2179, both in the range 1 to 300 µM, indicating that it was not mediated by P2Y1 receptors. This contrasts with the increase in cytosolic free Ca2+ concentration ([Ca2+]c) induced by 2-MeSADP, which has shown to be inhibited by A3P5P. Pertussis toxin abolished the inhibitory effect of both UTP and 2-MeSADP. After culture of cells for 48 h, the ability of 2-MeSADP to inhibit cyclic AMP accumulation was greatly diminished. Reverse transcriptase-polymerase chain reaction analysis revealed that during this culture period, there was a decline in the ability to detect transcripts for P2Y12 and P2Y13 receptors, both of which are activated by 2-MeSADP and negatively coupled to adenylyl cyclase. However, in freshly isolated cells, the P2Y12 and P2Y13 receptor antagonist, 2-propylthio-
,
-dichloromethylene-D-ATP (AR-C67085) (10 nM to 300 µM) did not alter the ability of 2-MeSADP to inhibit glucagon-stimulated cyclic AMP accumulation. We conclude that 2-MeSADP regulates rat hepatocyte glycogen phosphorylase by acting on P2Y1 receptors coupled to raised [Ca2+]c, and by inhibiting cyclic AMP levels by an unknown Gi-coupled receptor subtype, distinct from P2Y1, P2Y12, or P2Y13 receptors.
Address correspondence to: Professor M. R. Boarder, The Cell Signaling Laboratory, Leicester School of Pharmacy, The Hawthorn Building, De Montfort University, Leicester LE1 9BH. E-mail: mboarder{at}dmu.ac.uk
This article has been cited by other articles:
![]() |
A. I. Masyuk, S. A. Gradilone, J. M. Banales, B. Q. Huang, T. V. Masyuk, S.-O. Lee, P. L. Splinter, A. J. Stroope, and N. F. LaRusso Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G725 - G734. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Luo, C. J. Dixon, J. F. Hall, P. J. White, and M. R. Boarder A Role for Akt in Epidermal Growth Factor-Stimulated Cell Cycle Progression in Cultured Hepatocytes: Generation of a Hyperproliferative Window after Adenoviral Expression of Constitutively Active Akt J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 884 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Dixon, P. J. White, J. F. Hall, S. Kingston, and M. R. Boarder Regulation of Human Hepatocytes by P2Y Receptors: Control of Glycogen Phosphorylase, Ca2+, and Mitogen-Activated Protein Kinases J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1305 - 1313. [Abstract] [Full Text] [PDF] |
||||